<--- Back to Details
First PageDocument Content
Medicine / Clinical research / Pharmaceutical industry / Pharmaceuticals policy / Drug safety / Pharmacovigilance / Serious adverse event / Adverse event / Adverse effect / Pharmaceutical sciences / Pharmacology / Health
Medicine
Clinical research
Pharmaceutical industry
Pharmaceuticals policy
Drug safety
Pharmacovigilance
Serious adverse event
Adverse event
Adverse effect
Pharmaceutical sciences
Pharmacology
Health

GUIDELINE FOR GOOD CLINICAL PRACTICE

Add to Reading List

Source URL: www.fda.gov.

Download Document from Source Website

File Size: 121,27 KB

Share Document on Facebook

Similar Documents

Medical research / Clinical research / Pharmaceutical industry / Institutional review board / Clinical trial / Good clinical practice / Informed consent / Adverse event / Protocol / Ethics committee / Serious adverse event / University Malaya Medical Centre

Microsoft Word - SOP editedonlineversibaru.doc

DocID: 1rqX4 - View Document

Medical research / Medicine / Health / Clinical research / Clinical trials / Pharmaceutical industry / Clinical data management / Clinical pharmacology / Serious adverse event / Electronic patient-reported outcome / Trial master file / Case report form

Microsoft Word - Abbreviations List Approved Oct 2014

DocID: 1qCp5 - View Document

Medical research / Clinical research / Pharmaceutical industry / Good clinical practice / Clinical trial / Serious adverse event / Adverse event / AllTrials / Evidence-based medicine / Trial master file

Statement German Network for Evidence-based Medicine Berlin, 05 JulyThe German Network for Evidence-based Medicine endorses the

DocID: 1qiz3 - View Document

Clinical research / Pharmaceutical industry / Design of experiments / Medical ethics / Institutional review board / Clinical trial / Pharmacovigilance / Office for Human Research Protections / Adverse event / Human subject research / Serious adverse event / Adverse effect

Microsoft Word - Unanticipated_Problems

DocID: 1pvDq - View Document

Pharmaceuticals policy / Clinical research / Clinical pharmacology / Drug safety / World Health Organization / Pharmacovigilance / Uppsala Monitoring Centre / VigiBase / Adverse effect / Adverse drug reaction / Serious adverse event / Adverse event

PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015 Post marketing Control Division,

DocID: 1p9e5 - View Document